Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Induction of the Cdk inhibitor p21 by LY83583 inhibits tumor cell proliferation in a p53-independent manner
Dimitri Lodygin, … , Antje Menssen, Heiko Hermeking
Dimitri Lodygin, … , Antje Menssen, Heiko Hermeking
Published December 1, 2002
Citation Information: J Clin Invest. 2002;110(11):1717-1727. https://doi.org/10.1172/JCI16588.
View: Text | PDF
Article Aging

Induction of the Cdk inhibitor p21 by LY83583 inhibits tumor cell proliferation in a p53-independent manner

  • Text
  • PDF
Abstract

Research Article

Authors

Dimitri Lodygin, Antje Menssen, Heiko Hermeking

×

Figure 3

Options: View larger image (or click on image) Download as PowerPoint
Effects of LY on epithelial cancer cells. (a) Growth curves of MCF7, A-3...
Effects of LY on epithelial cancer cells. (a) Growth curves of MCF7, A-375, HCT116, and DLD1 cells. Cells were trypsinized at the indicated time points and cell numbers were determined. (b) Induction of p21 protein after treatment with LY. HCT116 colorectal cancer cells were treated with 1.5 μM LY for the indicated periods. Cell lysates were prepared and subjected to Western blot analysis. For details, see the Methods.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts